Position in VIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,285,376
+$1,052,300 QoQ
Shares Held
126,141
+384.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 237 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Derivatives in VIR
reported options exposure · as of Dec 31, 2024CallValue
$385,350
CallShares
52,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. VIR ranks #100 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in VIR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,285,376 | 126,141 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $233,076 | 26,013 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $125,828 | 20,867 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,583,468 | 277,315 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $541,094 | 107,360 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $347,963 | 53,698 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $1,572,690 | 214,263 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $385,350 | 52,500 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $393,225 | 52,500 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $776,713 | 103,700 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $475,349 | 53,410 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $906,910 | 101,900 | Call | Defined | 2024-08-14 | |
| 2023-12-31 | $2,231,861 | 221,855 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,617,646 | 172,641 | Shares | Defined | 2023-11-14 | |
| 2022-06-30 | $1,798,946 | 70,630 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,066,029 | 119,208 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $982,730 | 23,471 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $829,446 | 16,178 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||